Fig. 2From: Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastasesWaterfall plot summarizing maximum observed radiographic responses within the liver by RECIST criteria version 1.1Back to article page